n Southern African Journal of HIV Medicine - Boosting protease inhibitors with low-dose ritonavir - unravelling the mystery : boosting protease inhibitors

Volume 2006, Issue 24
  • ISSN : 1608-9693
  • E-ISSN: 2078-6751



The advent of highly active antiretroviral treatment (HAART) has had the dramatic effect of changing HIV infection from a relentlessly progressive disease with inevitable death to a disease that is chronic and manageable. The goal of HAART is to suppress HIV replication maximally, and thereby restore immunological function, reduce HIV-related morbidity and mortality, and improve quality of life. HIV-infected persons who qualify for treatment can be treated with a HAART regimen consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) combined with a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI).

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error